RECRUITING

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Official Title

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer (CTMS 18-0056)

Quick Facts

Study Start:2018-10-16

Study Completion:2029-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT03655015

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure. * Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care * Any clinical stage of lung cancer * Adult patients ≥18 years of age * Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history	* At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.

Inclusion Criteria

Exclusion Criteria

* Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
* Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care
* Any clinical stage of lung cancer
* Adult patients ≥18 years of age
* Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history

* At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.

Contacts and Locations

Study Contact

Josephine Taverna, MD

CONTACT

210-450-8234

tavernaj@uthscsa.edu

Principal Investigator

Josephine Taverna, MD

PRINCIPAL_INVESTIGATOR

UT Health San Antonio M.D. Anderson Cancer Center

Study Locations (Sites)

UT Health San Antonio, M.D. Anderson Cancer Center

San Antonio, Texas, 78229

United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center at San Antonio

Josephine Taverna, MD, PRINCIPAL_INVESTIGATOR, UT Health San Antonio M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-10-16

Study Completion Date2029-12

Study Record Updates

Study Start Date2018-10-16

Study Completion Date2029-12

Terms related to this study

Additional Relevant MeSH Terms

Lung Neoplasm